Rogue Nations Competing with the X-37B

The Air Force’s X-37B Orbital Test Vehicle Mission 5 successfully landed at NASA’s Kennedy Space Center Shuttle Landing Facility Oct. 27, 2019. The X-37B OTV is an experimental test program to demonstrate technologies for a reliable, reusable, unmanned space test platform for the U.S. Air Force. (Courtesy photo) source

America’s four greatest adversaries are investing in systems that can take out satellites on orbit, including funding laser systems, nuclear power and satellites that shadow American space vehicles.

Russia, China, Iran and North Korea are each researching counterspace capabilities — kinetic or nonkinetic ways to taking out systems in space — according to the annual Global Counterspace Capabilities report, released by the Secure World Foundation.

Defense News was given an exclusive preview of the report, which will available later today and was edited by Brian Weeden and Victoria Samson.

For the first time, the report includes data on the space situational awareness (SSA) capabilities of countries — that is, the ability of nations to track what is moving in various orbits. Japan and India are two nations investing heavily in that area, according to the report, while Iran appears to lag behind.

“This is important because you can’t protect [against] what you can’t see,” said Samson, the organization’s Washington office director. “This doesn’t mean that developing an SSA capability is an indication of an offensive counterspace program, as there are many reasons why you would want that capability. But it is needed if you want to go offensive.”

  The Indian Space Research Organisation’s (ISRO) GSAT-9 on board the Geosynchronous Satellite Launch Vehicle (GSLV-F09), launches in Sriharikota in the state of Andhra Pradesh on May 5, 2017. / AFP PHOTO / ARUN SANKAR (Photo credit should read ARUN SANKAR/AFP/Getty Images)

She also highlighted the fact that in the last year, four of the countries with counterspace investments — India, Japan, France and the U.S. — have launched new military organizations specifically to deal with space-related issues, including a focus, at least in part, on counterspace efforts. In addition, the NATO alliance declared space an “operational domain” in December.

The vast majority of counterspace capabilities continue to reside with Russia, China and the United States, but other nations are funding programs as well. France, India, Japan, Iran and North Korea are all known to be at least investing some money in counterspace efforts, whether through ballistic missile programs or non-kinetic means such as cyberattacks.

The most prominent counterspace example of the last year came from India, which in March controversially launched a missile at one of its satellites, blowing it up and spewing shrapnel around low-earth orbit.

So is a counterspace arms race underway? The authors say no, at least in the context of the nuclear arms race where each country is trying to match the other capability for capability.

Instead, “this is about developing a range of offensive and defensive capabilities to go after an opponent’s space assets while protecting your own,” said Weeden, the organization’s director of program planning. “And I think that’s unfortunately inevitable because more and more countries are using space for military purposes. That drives increased interest in how to counter those uses.”

Added Samson, “it now seems that if you want to be considered a major space power, it’s not enough to have your own satellites, or the ability to launch them, or even the ability to launch other country’s satellites. You want your own counterspace capability.”

The big three

When Pentagon and White House officials talked about the need for a Space Force last year, leaders emphasized a growing threat in space.

“For all their posturing about who’s ‘weaponizing’ space, the big three are all working on a lot of the same technologies and doing a lot of the same things,” particularly rendezvous and proximity operations (RPO) where satellites can maneuver near another nation’s system, said Weeden.

The big three in this case are China, Russian and the United States.

China has run multiple maneuvers with its space-based systems that may be RPO-related, but it’s hard to know whether those capabilities are being developed for counterspace use as opposed to intelligence gathering, the report said.

When it comes to Chinese capabilities, Weeden said to focus on the ground-based anti-satellite weaponry — perhaps not a surprise, given China declared itself a player in counterspace technology by destroying one of its own satellites in 2007.

Beijing is investing in at least one, and perhaps as many as three, kinetic anti-satellite capabilities, “either as dedicated counterspace systems or as mid-course missile defense systems that could provide counterspace capabilities,” according to the report.

“It was robustly tested and appears to be operationally deployed,” Weeden said of those capabilities. “As long as the U.S. still relies on small numbers of very expensive satellites in LEO, I think it will prove to be a significant deterrent.”

While China often becomes the focus of public comments from Defense officials, Weeden said to keep an eye on Moscow, as he was “a bit shocked by the breadth of Russian counterspace programs. For all the concern and hype in the U.S. about China, Russia seems to be putting the most into counterspace.”

Those efforts include the Nudol, a ground-launched ballistic missile designed to be capable of intercepting targets in low-earth orbit; three different programs focused on RPO capabilities; the rebirth of an 1980s era program involving a large laser, to either dazzle or damage a satellite, carried about an IL-76MD-90A transport aircraft; a newly-discovered program called Ekipazh, which involves a nuclear reactor to power a large payload of on-orbit jammers; and what Weeden describes as a “massive” upgrade to SSA capabilities.

“All of that spells a very potent, more operationally-integrated, and more battle-tested package than what I’m seeing in China,” he warned. He added that he believes the public focus on China to be “part of the broader narrative the Trump administration is trying to push with China being the long-term threat they want to focus on. It also helps sell the narrative they’re trying to push on human spaceflight and exploration as well.”

As for the United States, the military has focused more on SSA and defensive counterspace capabilities, a trend Weeden says is due to America being the most reliant on space of the three countries, and hence must “protect its capabilities if it hopes to win a future conflict against Russia or China.” America’s SSA capabilities, in particular, remain well ahead of the rest of the world.

Which isn’t to say the U.S. is skipping out on counterspace investments either. America has a number of options for electronic warfare in space, including proven capabilities to jam enemy receivers within an area of operations; assets with RPO capabilities; and operational midcourse missile defense interceptors that have been demonstrated against low orbit satellites. In addition, there are plans to invest in prototyping directed energy capabilities for space.

One capability to keep an eye on is the X-37B, a spaceplane program that has made five trips into orbit and back to earth. In total, the spacecrafts have spent 2,865 days on orbit cumulatively over its five missions, with its last trip consisting of 780 days in space — more than two years.

The Air Force has been secretive about X-37B missions, often talking broadly about it conducting experiments in space; analysts have long believed that the mission set has at least something to do with counterspace capabilities. That belief was only strengthened by what happened during its last trip during which researchers believe it was used to launch a trio of small cubesats which were not registered in international tracking databases.

“The secret deployment of multiple small satellites raises additional questions about the mission of the X-37B. It suggests that the X-37B may have a mission to serve as a covert satellite deployment platform. The secrecy surrounding both the X-37B and the deployment may indicate they are part of a covert intelligence program, but it may also indicate the testing of offensive technologies or capabilities,” the authors wrote in the report. “The failure to even catalog the deployed satellites, something that is done even for classified U.S. military and intelligence satellites, calls into question the trustworthiness of the public SSA data provided by the U.S. military.”

And that creates potential diplomatic issues, at a time that the need for open discussions about space capabilities across nations should be growing, warned Samson.

“The Russians and Chinese have always pointed at the secrecy surrounding the X-37B program as evidence of malevolent intentions by the United States,” she said. “The fact that the U.S. released objects from the X-37B and didn’t register them feeds absolutely into that narrative and causes ripple effects that harm other multilateral discussions on space security and stability.”

China Supplied Faulty Coronavirus Test Kits

Seems to be a systemic problem with China as in 2017, the Chinese Communist Party issued a sizable medical equipment recall for faulty quality. It is unclear just what equipment was included but the CCP said they would reissue equipment under tighter controls. Swell.

China Supplied Faulty Coronavirus Test Kits to Spain, Czech Republic source

Translated from El Pais newspaper:

The much-announced rapid tests for coronaviruses with which the Government wanted to start testing the broader layers of the population to find out what is the real size of the contagion in Spain do not work well. This has been confirmed by several microbiology laboratories of large hospitals in the analyzes that have been made of the kits recently arrived from China. The results of these preliminary tests are discouraging: “They do not detect the positive cases as expected,” says a source who has participated in the tests and who asks for anonymity.

The rapid tests, manufactured by the Chinese company Bioeasy, based in Shenzhen, one of the technological poles of the Asian country, have a sensitivity of 30%, when it should be above 80%, these sources indicate. One of the microbiologists who has analyzed the Chinese test assures: “With that value it does not make sense to use these tests.” The conclusion of the experts who have evaluated these detection kits is that they will have to continue using the current test, the PCR. This has been reported to the Carlos III Health Institute, under the Ministry of Health.

The price of the sale of Chinese medical equipment to Spain was $467 million. In the transaction of medical equipment was 950 ventilators, 5.5 million testing kits and 11 million gloves and 500 million protective face masks. Chinese blamed one of its own companies called Bioesy and declared the company was not licensed. Okay, sure Beijing.

***

From NR:

Up to 80 percent of the 150,000 portable, quick coronavirus test kits China delivered to the Czech Republic earlier this month were faulty, according to local Czech news site Expats.cz. The tests can produce a result in 10 or 15 minutes but are usually less accurate than other tests. Because of the high error rate, the country will continue to rely on conventional laboratory tests, of which they perform about 900 a day.

The country’s Health Ministry paid $546,000 for 100,000 of the test kits, while the Interior Ministry paid for the other 50,000.

Deputy Prime Minister and Interior Minister Jan Hamacek downplayed the discovery that many of the tests were faulty, blaming it on a possible wrong methodology and saying the kits can still be used “when the disease has been around for some time,” or when “someone returns after quarantine after fourteen days.”

“In my opinion, this is not about some scandalous revelation that it is not working,” Hamacek said.

Meanwhile, Spain, which has more than 56,000 infected people and more than 4,000 coronavirus deaths, the second-highest number of fatalities in the world after Italy, found that the rapid coronavirus test kits it purchased from Chinese company Bioeasy only correctly identified 30 percent of virus cases, according to Spanish newspaper El Pais.

The director Spain’s Center for Health Alerts and Emergencies, Fernando Simón, said Spain tested 9,000 of the test kits and will return them based on their high error rate.

Studies performed on the tests which discovered the high error rate caused the Spanish Society of Infectious Diseases and Clinical Microbiology to recommend officially that the tests not be used.

The Chinese embassy in Spain claimed the Bioeasy products are not included in the products China has been supplying to countries where the virus has broken out.

Spain sends back Chinese coronavirus testing kits because they don ... source

Spain has 49,515 confirmed cases and there have been so many deaths in one small town, the officials had to use an ice skating rink to hold the bodies for burial processing.

$2T Stimulus COVID Recovery Must Exclude Chinese Corps

So, Congress appears to have a deal for an estimated $2 trillion to backstop the economy, jobs and small to large domestic companies.

Waldorf Astoria, most expensive hotel in the world: in ... source
Enter Florida Congressman Matt Gaetz:

Washington, D.C. — Congressman Matt Gaetz (FL-01) introduced legislation today to prevent any funds appropriated by the U.S. Congress, including coronavirus relief funds, from being distributed to businesses owned by the Chinese government. The “No CHINA (Chinese Handouts In National Assistance) Act” would ensure that American taxpayer dollars used in any COVID-19 funding package do not support the communist regime in China, or businesses owned by the Chinese government.

China’s inaction, distortion of data, and outright lies have exacerbated the global coronavirus epidemic, and helped fuel its rapid global spread. Under the “No CHINA Act,” companies owned by the Chinese government will not receive any American taxpayer dollars from Congressional aid packages.

“Every single American worker displaced by COVID19 should be fully compensated, before one nickel from our treasury goes to Chinese-owned corporations operating here in the United States. Full stop.

“The global coronavirus pandemic has been exacerbated by the Chinese government’s malicious misinformation and propaganda campaign against the United States and its citizens. Allowing American taxpayers’ money to go to companies owned by the Communist Chinese government is antithetical to our ‘America First’ agenda.

“I’m proud to introduce the “No CHINA Act” today, which prevents appropriated money, including coronavirus relief funds, from being disbursed to businesses owned by the Chinese government. Chinese corporations operating in America must not be eligible for the upcoming trillion-dollar bailout, now or ever,” Congressman Gaetz said. Click here for text of his proposed legislation.

This is an excellent matter to consider, while others in Congress are proposing legislation beyond condemnation and investigation in to China’s virus activities that include reparations for the financial damage to the United States and even demanding that China forgive the U.S. debt held by China estimated at $1.8 trillion.

But, let’s look deeper into what the Communist Chinese Party/Beijing actually owns in the United States for context and owned by Chinese oligarchs. By the way, there is precedence for seizing real property. We did so with the real estate owned in the United States by Iran.

AMC Theaters to launch On Demand movie service – HD Report

AMC Theaters.

Smithfield Foods

Legendary Entertainment Group

Haier/ GE

Waldorf Astoria Hotel

Strategic Hotels and Resorts (Ritz Carton/Four Seasons)

Riot Games

Ingram Micro (distributes everything from Apple’s iPhone to Cisco’s network equipment)

Motorola Lenovo

As of 2017, Chinese conglomerates in New York City receiving 46% of total Chinese investment, the San Francisco Bay Area getting 15%, Los Angeles 7%, Chicago 5% and Seattle 2% in real estate. New York City, the main recipient of Chinese investment into commercial real estate, was home to many of the largest deals of the year. Of the ten largest transactions in 2016, half were in Manhattan and 63% of those deals were in office buildings. More here.

*** Beyond the Hunter Biden and father/ presidential candidate Joe Biden deals with China, still being investigated…..

The American Enterprise Institute and the Heritage Foundation’s China Global Investment Tracker follows large Chinese investments, excluding bonds, around the world.

The leading recipient of these kinds of investments is the United States, which received over $180 billion from January 2005 through December 2019. Chinese investment in 2019, though, barely exceeded $3 billion. The US has passed legislation limiting Chinese access to not only technology but also personal data, so the 2017 spending level of $25 billion will be difficult to regain.

The deals described in the tracker are worth $100 million or more. More important, they are voluntary transactions that let Americans make their own choices. Chinese purchases benefit Americans who hold desirable assets—city property and large corporations but also individual family homes (not in the tracker). Chinese investment helps support a small number of American jobs.

Against that, China is not a friend. The US certainly should not ban Chinese investment, but, as Congress has directed, Chinese firms and individuals should not be permitted to buy advanced technology that could have military uses. Chinese firms that receive stolen intellectual property should be punished. Most Chinese firms have little familiarity with a competitive market under rule of law, so their ability to obey the law is in doubt. In particular, Chinese firms cannot be trusted with Americans’ personal data. Within these guidelines, Chinese investment in the US can be positive for both countries.

Hey CNN/MSNBC for 15 Years, it has Been China’s SARS-CoV

So, President Trump is right…how about media being real journalists for a change? Tell Hillary, CNN and the rest that Trump is hardly “racist” and “xenophobic”.

Let’s travel over to Basel, Switzerland shall we?

Primer: MDPI is Molecular Diversity Preservation International/Multidisciplinary Digital Publishing Institute founded in 1996 located in Basel. The organization is an open access repository of medical journals where each paper has citations from medical academics and experts. Health issues include various human health conditions such as obesity, autism, Alzheimer’s disease, cancer and many many others.

Image result for sar cov china

So, media, when it comes to China and SAR-CoV, review their summary. (BTW, it is full of citations)

1. Introduction

Fifteen years after the first highly pathogenic human coronavirus caused the severe acute respiratory syndrome coronavirus (SARS-CoV) outbreak, another severe acute diarrhea syndrome coronavirus (SADS-CoV) devastated livestock production by causing fatal diseases in pigs. Both outbreaks began in China and were caused by coronaviruses of bat origin [1,2]. This increased the urgency to study bat coronaviruses in China to understand their potential of causing another virus outbreak.
In this review, we collected information from past epidemiology studies on bat coronaviruses in China, including the virus species identified, their host species, and their geographical distributions. We also discuss the future prospects of bat coronaviruses cross-species transmission and spread in China.

2. Why Study Bat Coronaviruses in China?

2.1. Coronavirus Taxonomy

Coronaviruses (CoVs) belong to the subfamily Orthocoronavirinae in the family Coronaviridae and the order Nidovirales. CoVs have an enveloped, crown-like viral particle from which they were named after. The CoV genome is a positive-sense, single-strand RNA (+ssRNA), 27–32 kb in size, which is the second largest of all RNA virus genomes. Typically, two thirds of the genomic RNA encodes for two large overlapping polyproteins, ORF1a and ORF1b, that are processed into the viral polymerase (RdRp) and other nonstructural proteins involved in RNA synthesis or host response modulation. The other third of the genome encodes for four structural proteins (spike (S), envelope (E), membrane (M), and nucleocapsid (N)) and other accessory proteins. While the ORF1a/ORF1b and the four structural proteins are relatively consistent, the length of the CoV genome is largely dependent on the number and size of accessory proteins [3].
Compared with other RNA viruses, the expanded genome size of CoVs is believed to be associated with increased replication fidelity, after acquiring genes encoding RNA-processing enzymes [4]. Genome expansion further facilitates the acquisition of genes encoding accessory proteins that are beneficial for CoVs to adapt to a specific host [5]. As a result, genome changes caused by recombination, gene interchange, and gene insertion or deletion are common among CoVs. The CoV subfamily is expanding rapidly, due to the application of next generation sequencing which has increased the detection and identification of new CoV species. As a result, CoV taxonomy is constantly changing. According to the latest International Committee of Taxonomy of Viruses (ICTV) classification, there are four genera (α-, β-, δ-, and γ-) consisting of thirty-eight unique species in the subfamily [6]. The number of species will continue to increase, as there are still many unclassified CoVs [7,8].
CoVs cause disease in a variety of domestic and wild animals as well as in humans, where α- and β-CoVs mainly infect mammals and γ- and δ-CoVs mainly infect birds (Table 1). Two highly pathogenic β-CoVs, SARS-CoV, and MERS-CoV have caused pandemics in humans since 2002 [1,9]. Originating in China and then spreading to other parts of the world, SARS-CoV infected around 8000 individuals with an overall mortality of 10% during the 2002–2003 pandemic [1]. Since its emergence in 2012 in the Middle East, MERS-CoV spread to 27 countries, resulting in 2249 laboratory-confirmed cases of infection with an average mortality of 35.5% (until September 2018) [9]. Besides these two viruses, α-CoVs 229E and NL63 and β-CoVs OC43 and HKU1 can also cause respiratory diseases in humans [10]. Moreover, CoVs cause pandemic disease in domestic and wild animals (Table 1). SADS-CoV was recently identified as the etiological agent responsible for a large-scale outbreak of fatal disease in pigs in China that caused the death of more than 20,000 piglets [2]. Porcine epidemic diarrhea virus (PEDV) and transmissible gastroenteritis virus (TGEV) that belong to α-CoV and porcine δ-CoV (PDCoV) are also important emerging and re-emerging viruses in pigs that pose significant economic threat to the swine industry [11]. In addition, avian infectious bronchitis virus (IBV, γ-CoV) causes a highly contagious disease that affects poultry production worldwide [12]. Coronaviruses have also been associated with catarrhal gastroenteritis in mink (MCoV) and whale deaths (BWCoV-SW1) [13,14].

Read on here if you need to.

Wonder if candidate Joe Biden or Bernie Sanders will reveal this as truth in their ad attacks?

Terrifying Facts about our Prescription Drugs

Congress, the FDA and the Pentagon is well aware of how tainted many of the drugs from China.

Priest, a retired Army colonel, delivered these remarks July 31 on Capitol Hill at a meeting of the U.S.-China Economic and Security Review Commission. The commission in-part investigates national security risks related to foreign trade and provides recommendations to Congress.

The U.S. purchases of drugs from foreign countries came under scrutiny earlier this year, when the Food and Drug Administration discovered that carcinogens in generic products used to treat high blood pressure and heart failure. Some of those drugs made their way to military treatment facilities, where veterans pick up their prescriptions.

The 10 most prescribed drugs are found here.

Made in China: new and potentially lifesaving drugs - SFGate source

The common debate on Capitol Hill has been the cost of prescription drugs, when the 800 lb. gorilla in the room has been uncontrolled ingredients in over-the-counter drugs as well as prescription that legislators have known about but ignored. The same debate continues with medical devices manufactured in China. The United States does not even produce vitamin C. Yeesh, and China has been called a drug cartel of distinction because of trafficking fentanyl.

Communist China controls 80% of American drugs - Metro ...

GoodRx, commercials often seen on TV to save money by using their APP recently published the following about bizarre ingredients:

1) Gold

Gold, of course, has been used for thousands of years in jewelry, but few know that it has therapeutic properties. Today, we have the oral anti-inflammatory medication, Ridaura (auranofin), which is used to treat rheumatoid arthritis. Likewise, an injectable gold known as gold sodium thiomalate (GST) is injected weekly or monthly into joints to treat arthritis. Fancy.

2) Saliva of a Gila monster

Ok, that’s slightly misleading. Exenatide, the active ingredient in Byetta and Bydureon, and an important medicine to control blood sugar in diabetics, is a man-made form of a protein found in the saliva of the Gila monster, a poisonous lizard native to the southwestern United States. Still weird.

3) Urine from pregnant horses

Premarin, a medication used as hormone replacement therapy to treat symptoms of menopause, comes from estrogen hormones isolated from pregnant horse urine. Yep.

4) Rooster combs

Synvisc and Synvisc-One (Hylan G-F 20), injectable medications given for knee arthritis to provide pain relief for up to six months, both contain hyaluronan, which is made from chicken combs. Hyaluronan makes joint fluid more flexible and fluid, so there’s better shock absorption in the knee. Cock-a-doodle-doo.

5) Poop

“Fecal pills”, used in fecal microbiota transplantations (FMTs), are capsules containing frozen bacteria collected from the stool of donor patients. Fecal pills taken orally have been shown to be 96% effective in treating C. diff diarrhea. A truly hard pill to swallow.

6) Formaldehyde

Yes, you heard that right. Formaldehyde, the main ingredient in embalming fluid and a common substance in household cleaning products, is used in medicine. Hiprex, which contains methenamine, is making a resurgence in popularity as an effective medication for preventing recurrent urinary tract infections. And methenamine works when it’s converted in urine to formaldehyde, the same chemical we use to embalm dead bodies.

7) Fish

While not exactly gross, the contribution of marine life to medicines is worth mentioning. Lovaza, the only pharmaceutical-grade fish oil on the market, is used to lower triglycerides, a type of fat found in your blood that can increase your risk of heart disease at high enough levels. The oils in cooked masses of fish are separated from the solids—and that’s how you get Lovaza. Ok, not so bad.

8) Urine from postmenopausal women

The urine of postmenopausal women is in many follicle stimulating hormone (FSH) preparations, including Repronex and Bravelle, which are used to treat infertility. Unlike donated blood, where the donation can be traced to one donor, these medications are made with pooled urine from multiple donors, so there’s some concern over safety. That’s why Follistim, which contains synthetic FSH is a good alternative. Pools of urine.

9) Pig pancreas

Creon (pancrelipase) is made from the pancreas of pigs and is available only with a prescription. Creon is used in patients who lack full pancreatic functionality, whether because of cystic fibrosis, chronic pancreatitis, type 1 diabetes or removal of the pancreas. Oink.

10) Pig thyroid gland

Armour thyroid comes from the dried out thyroid glands of pigs. Armour thyroid is prescribed for underactive thyroid, or hypothyroidism, and is less tightly regulated than Synthroid, a manufactured form of thyroid hormone. Oink take 2.

Setting aside for a moment how the United States has in recent days complained about China’s lack of cooperation with the United States over COVID-19, other nations have as well. Just a few day ago, the UK published an immediate report stating that China was to blame and noted that the lack of truth from China has caused the global health crisis.

So, there is an immediate movement authorized by President Trump to fast track domestic manufacture production of many top medicines not only for treating COVID-19 but other most prescribed drugs as well. The FDA is fast tracking several variations of chloroquine, which has several names including Aralen,Plaquenil or Avigan already used to treat COVID-19. Yes, however, this comes from China as well. In fact Wuhan and Shenzhen treated coronavirus patients with favipiravir with excellent success, meaning patient’s tests are negative just after 3-4 days.

***

Sen. Tom Cotton (R., Ark.) introduced legislation Thursday to repatriate pharmaceutical manufacturing from China to America, aiming to reduce a dependency that could seriously limit the U.S. coronavirus response.

The bill, which Cotton introduced with Rep. Mike Gallagher (R., Wis.), aims to severely curtail the volume of Chinese active pharmaceutical ingredients (APIs) from the U.S. medical drug supply. The PRC currently produces most of the world’s APIs—the “active ingredients” in commonly used drugs—leaving the United States and other nations critically dependent on it for medicines.

Cotton’s is just the latest proposal to onshore pharmaceutical supply chains, including a similar one from Sen. Marco Rubio (R., Fla.) and rumblings from the White House about a “buy American” executive order. Prompted by the coronavirus pandemic, many are beginning to see the cost-savings from Chinese-made pharmaceuticals as not worth the risk of undersupply during another pandemic, or during a potential conflict with America’s main geostrategic rival. More here.